Cisen Pharmaceutical Co., Ltd. (SHA:603367)
14.26
-0.02 (-0.14%)
Apr 3, 2025, 2:45 PM CST
Cisen Pharmaceutical Revenue
Cisen Pharmaceutical had revenue of 931.73M CNY in the quarter ending September 30, 2024, a decrease of -5.90%. This brings the company's revenue in the last twelve months to 4.25B, down -2.51% year-over-year. In the year 2023, Cisen Pharmaceutical had annual revenue of 4.46B with 9.75% growth.
Revenue (ttm)
4.25B
Revenue Growth
-2.51%
P/S Ratio
1.52
Revenue / Employee
1.25M
Employees
3,402
Market Cap
6.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.46B | 396.26M | 9.75% |
Dec 31, 2022 | 4.07B | 283.50M | 7.49% |
Dec 31, 2021 | 3.78B | 108.43M | 2.95% |
Dec 31, 2020 | 3.67B | -438.63M | -10.66% |
Dec 31, 2019 | 4.11B | 304.71M | 8.00% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |
Sichuan Biokin Pharmaceutical | 5.82B |